Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Accumulated Expenses (2024 - 2025)

Xenetic Biosciences' Accumulated Expenses history spans 5 years, with the latest figure at $100000.0 for Q3 2025.

  • For Q3 2025, Accumulated Expenses fell 66.67% year-over-year to $100000.0; the TTM value through Sep 2025 reached $100000.0, down 66.67%, while the annual FY2024 figure was $200000.0, N/A changed from the prior year.
  • Accumulated Expenses reached $100000.0 in Q3 2025 per XBIO's latest filing, roughly flat from $100000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $800000.0 in Q2 2024 to a low of $100000.0 in Q2 2025.